1-3 of 3
Florentia Kaguelidou
Close
Sort by
Journal Articles

Efficacy and Tolerance of the BNT162b2 Vaccine in Children with Acute Leukemia and Their Siblings: Results of the Phase I-II Pacific Trial

Fanny Alby Laurent, Amani Ouedrani, Pierre Jatteau, Marion Strullu, Claire Montlahuc, Chaima Mrad, Audrey Guilmatre, Maxime Ferreboeuf, Anne-France Ray-Lunven, Florentia Kaguelidou, Lucienne Chatenoud, Laurence Morand-Joubert, Sylvie Chevret, Arnaud Petit
Journal: Blood
Blood (2023) 142 (Supplement 1): 4246.
https://doi.org/10.1182/blood-2023-181899
Published: 2023
Journal Articles

Population Pharmacokinetics of Cefotaxime and Dosage Recommendations in Children with Sickle Cell Disease

Bérengère Koehl, MD PhD, Elsa Maksoud, engineer, Phuong Ha, engineer, Wei Zhao, engineer, Florentia Kaguelidou, MD PhD, Malika Benkerrou, MD, Patricia Mariani, MD, Mathie Lorrot, MD PhD, Albert Faye, MD PhD, Evelyne Jacqz-Aigrain, MD PhD, Andre Baruchel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 975.
https://doi.org/10.1182/blood.V130.Suppl_1.975.975
Published: 2017
Journal Articles

Antithrombin, Protein C, Protein S and Activated Protein C Resistance in the General Healthy Chinese Population: Normal Plasmatic Ranges and Genetic Defects.

Yongqiang Zhao, MD, Xuefeng Wang, MD, Qiulan Ding, MD, Xuqian Wei, MD, Tienan Zhu, MD, Florentia Kaguelidou, MD, Renchi Yang, MD, Changgeng Ruan, MD, Zhaoyue Wang, MD, Xia Bai, MD, Nicole Schlegel, MD
Journal: Blood
Blood (2007) 110 (11): 3982.
https://doi.org/10.1182/blood.V110.11.3982.3982
Published: 2007